TP53 and neoplasm: Prognostically, the DLBCL had multiple favorable markers including germinal center origin (MUM-1 negative and BCL6 positive), low proliferative index (Ki-67 positive for only 25% of tumor cells), enhanced T-cell immune response (>60% CD3 positive cells), and low staining for P53 (only 10% of tumor cells).